BIOLASE (NASDAQ:BIOL) Now Covered by Analysts at StockNews.com

Equities researchers at StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL) in a report released on Monday. The brokerage set a “sell” rating on the medical technology company’s stock.

A number of other equities research analysts have also recently commented on BIOL. Benchmark reiterated a “speculative buy” rating and issued a $0.40 target price on shares of BIOLASE in a research report on Wednesday, October 2nd. Ascendiant Capital Markets cut their price objective on shares of BIOLASE from $3.50 to $2.00 and set a “buy” rating for the company in a report on Tuesday, September 3rd.

BIOLASE Trading Down 72.0 %

NASDAQ:BIOL opened at $0.02 on Monday. The stock has a 50 day moving average of $0.04 and a two-hundred day moving average of $0.09. BIOLASE has a 12 month low of $0.02 and a 12 month high of $1.94. The firm has a market cap of $581,281.80, a P/E ratio of 0.00 and a beta of 0.67.

BIOLASE (NASDAQ:BIOL) last issued its quarterly earnings results on Thursday, August 8th. The medical technology company reported ($0.08) earnings per share (EPS) for the quarter. BIOLASE had a negative return on equity of 1,782.73% and a negative net margin of 41.65%. The firm had revenue of $11.56 million during the quarter.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in BIOLASE stock. Virtu Financial LLC increased its position in shares of BIOLASE, Inc. (NASDAQ:BIOL) by 1,068.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 143,537 shares of the medical technology company’s stock after purchasing an additional 131,248 shares during the period. Virtu Financial LLC owned 0.43% of BIOLASE worth $27,000 at the end of the most recent quarter. Institutional investors and hedge funds own 8.79% of the company’s stock.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.